Aurinia Pharmaceuticals

Three Biotechs Shutter Clinical Programs After Futility Analysis or Failed Trials
BioSpace
Tue, 11/3/20 - 09:29 pm
Jounce Therapeutics
vopratelimab
Santhera
vamorolone
Puldysa
Aurinia Pharmaceuticals
FOS
A little biotech's second crack at dry eye disease comes up short. And this time there will be no extra shot at success
Endpoints
Mon, 11/2/20 - 11:07 pm
Aurinia Pharmaceuticals
VOS
dry eye disease
clinical trials
Aurinia initiates rolling submission of a new drug application to the FDA for Voclosporin in the treatment of lupus nephritis
Pharmaceutical Business Review
Tue, 03/17/20 - 12:12 pm
Aurinia Pharmaceuticals
FDA
voclosporin
lupus nephritis
2 Top Biotech Buyout Candidates
Motley Fool
Wed, 12/11/19 - 10:38 am
M&A
Amarin
Vascepa
Aurinia Pharmaceuticals
voclosporin
Aurinia’s drug to treat autoimmune kidney disease hits its goals in late-stage trial
Stat
Wed, 12/4/19 - 11:15 pm
Aurinia Pharmaceuticals
lupus nephritis
clinical trials
voclosporin
autoimmune kidney disease
Here’s Why Aurinia Pharmaceuticals Stock Jumped Higher Today
Motley Fool
Tue, 11/26/19 - 11:44 pm
Aurinia Pharmaceuticals
clinical trials
voclosporin
lupus nephritis
Aurinia eye drug falls short in improving tolerability versus Restasis, but beats on efficacy
Endpoints
Tue, 01/22/19 - 11:43 am
Aurinia Pharmaceuticals
voclosporin
eye health
dry eye disease
Allergan
Restasis
An Exciting New Drug Is in Clinical Trials for Aurinia Pharmaceuticals
Motley Fool
Wed, 07/26/17 - 12:07 am
clinical trials
Aurinia Pharmaceuticals
FDA
voclosporin
lupus
kidney disease
3 Small Biotech Stocks Being Run by Proven Winners
Motley Fool
Mon, 07/17/17 - 11:15 am
biotech
Axovant
Esperion Therapeutics
Aurinia Pharmaceuticals
Richard Glickman
David Hung
Roger Newton
Athersys And Aurinia Target Human And Animal Health
Seeking Alpha
Tue, 06/27/17 - 09:36 am
Athersys
Aurinia Pharmaceuticals
animal health
stem cells
New Data Suggests Aurinia Pharmaceuticals Is Onto Something Big
Motley Fool
Wed, 06/21/17 - 09:40 am
Aurinia Pharmaceuticals
voclosporin
CellCept
lupus nephritis
3 Best Biotech Stocks During Trump's First 100 Days
Motley Fool
Tue, 05/2/17 - 10:04 am
biotech stocks
Donald Trump
Esperion Therapeutics
Aurinia Pharmaceuticals
TG Therapeutics

Pages